SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home â–¸ Investors
Syngene International Limited is an integrated research, development and manufacturing organisation providing scientific services – from early discovery to commercial supply. We offer services across wide range of sectors including pharmaceutical, nutrition, animal health, consumer goods and speciality chemical companies.
Our long-term collaborations ensures predictable and stable cash flows. Our strong balance sheet and financial performance has helped us in reassuring clients that we will be able to support their investments in terms of both capabilities and capacities.
Our ability to make these investments helps strengthen trust and engagement with our clients, which enhances our ability to retain them and extend our engagement across multiple platforms.
© 2023. Syngene International Limited